JP Morgan Chase
ONCY

JP Morgan Chase’s Oncolytics Biotech ONCY Stock Holding History

JP Morgan Chase’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03K Buy
+1,277
New +$1.27K ﹤0.01% 7118
2024
Q2 		– Sell
-11,500
Closed -$12.2K – 7643
2024
Q1 		$12.2K Hold
11,500
– – ﹤0.01% 6316
2023
Q4 		$15.5K Buy
+11,500
New +$18K ﹤0.01% 6309
2022
Q1 		– Sell
-36,235
Closed -$50K – 6889
2021
Q4 		$50K Sell
36,235
-111,238
-75% -$206K ﹤0.01% 5945
2021
Q3 		$900K Sell
147,473
-3,200
-2% -$7.25K ﹤0.01% 4393
2021
Q2 		$919K Buy
150,673
+94,390
+168% +$289K ﹤0.01% 4362
2021
Q1 		$214K Buy
+56,283
New +$168K ﹤0.01% 5121
2020
Q4 		– Sell
-16,483
Closed -$101K – 5846
2020
Q3 		$101K Buy
16,483
+11,200
+212% +$20.5K ﹤0.01% 4688
2020
Q2 		$10K Buy
+5,283
New +$9.95K ﹤0.01% 5123

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase's ONCY Position: Q1 2026 in Review

JP Morgan Chase opened a new position in Oncolytics Biotech (ONCY) in Q1 2026: 1,277 shares worth $1.03K. The stake represents ﹤0.01% of the portfolio and ranks #7118 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in ONCY as recently as Q1 2024.

JP Morgan Chase first reported a position in ONCY in Q2 2020 and has held it in 9 quarters since. The position peaked at $919K in Q2 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • JP Morgan Chase held 1,277 shares of Oncolytics Biotech worth $1.03K as of Q1 2026.
  • Oncolytics Biotech was a new JP Morgan Chase position in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7118 holding.
  • JP Morgan Chase first reported a position in Oncolytics Biotech in Q2 2020 and has held it in 9 quarters since.
  • JP Morgan Chase's Oncolytics Biotech position peaked at $919K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.